The disparate outcomes reported by these two teams underscore the potential dual role of SOX17, akin to the extensively studied TP53, wherein it may function as both a tumor suppressor and a promoter of tumor progression under distinct circumstances. This evidence concerns the gene TP53 and neoplasm.